Michael Oinonen
-
- Antibiotic Use and Resistance 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 2
- Clinical Biochemistry top 5%
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 3
-
- Microscopic Colitis 4
- Pneumonia and Respiratory Infections 2
-
- Clostridium difficile and Clostridium perfringens research 4
-
- Patient Satisfaction in Healthcare 2
- Health Sciences Research and Education 2
- Co-authors
- Amy PakyzRonald E. PolkConan MacDougallSpencer E. HarpeHolly E. GurgleNorman V. CarrollOmar M. IbrahimRon E. Polk
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- Infection Control and Hospital Epidemiology (4 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Journal of Medical Systems (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Michael Oinonen
17 papers receiving 512 citations
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 228
- Molecular Medicine 110
- Critical Care and Intensive Care Medicine 82
- Clinical Biochemistry 77
- Geriatrics and Gerontology 32
Countries citing papers authored by Michael Oinonen
This map shows the geographic impact of Michael Oinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Oinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Oinonen more than expected).
Fields of papers citing papers by Michael Oinonen
This network shows the impact of papers produced by Michael Oinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Oinonen. The network helps show where Michael Oinonen may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Michael Oinonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2012 | 26 | |
| 3 | 2012 | 11 | |
| 4 | 2011 | 29 | |
| 5 | 2011 | 21 | |
| 6 | 2010 | 7 | |
| 7 | 2009 | 47 | |
| 8 | 2009 | 46 | |
| 9 | 2009 | 125 | |
| 10 | 2008 | 140 | |
| 11 | 2006 | 18 | |
| 12 | 2006 | 21 | |
| 13 | 2004 | 1 | |
| 14 | 2003 | 11 | |
| 15 | 2001 | 11 | |
| 16 | 2000 | 4 | |
| 17 | 2000 | 2 |
About Michael Oinonen
Michael Oinonen is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Molecular Medicine, Infectious Diseases and Epidemiology, having authored 17 papers that have together received 521 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (4 papers), Microscopic Colitis (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Pneumonia and Respiratory Infections (2 papers), Patient Satisfaction in Healthcare (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Health Sciences Research and Education (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (228 citations), Molecular Medicine (110 citations), Critical Care and Intensive Care Medicine (82 citations), Clinical Biochemistry (77 citations) and Geriatrics and Gerontology (32 citations). Michael Oinonen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Amy Pakyz, Ronald E. Polk, Conan MacDougall, Spencer E. Harpe, Holly E. Gurgle, Norman V. Carroll, Omar M. Ibrahim, Ron E. Polk, Mera Ababneh and Karl Matuszewski. Their work appears in journals such as Infection Control and Hospital Epidemiology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Medical Systems, American Journal of Health-System Pharmacy and American Journal of Medical Quality.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.